Abstract
Interest in the chemotherapeutic activity of thiosemicarbazones stems from the discovery of Domagk et al. (1946) that certain monothiosemicarbazones have antitubercular action. Since then, a great many mono- and dithiosemicarbazones have been synthesized and assayed for possible chemotherapeutic activity in a number of systems. Among these compounds are a number of bis(thiosemicarbazones) of α-ketoaldehydes or diketones which have been found to show antimicrobial, antiparasitic, and antitumor activities (Barrett et al., 1965; Michaels et al., 1962; French and Freedlander, 1958; Barry et al., 1970).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bähr, G.: Über Emprotide Schwermetall-Inner-Complexe Der α-Diketon-Dithiosemicarbazone (Thiazone). I. Z. f. Anorg. Allg. Chemie 268, 351–363 (1952).
Bähr, G.: Über Emprotide Schwermetall-Inner-Complexe Der α-Diketon-Dithiosemicarbazone (Thiazone). II. Z. f. Anorg. Allg. Chemie 273, 325–332 (1953).
Barrett, P. A., Beveridge, E., Bradley, P. L., Brown, C. G. D., Bushby, S. R. M., Clarke, M. L., Neal, R. A., Smith, R., Wilde, J. K. H.: Biological activities of some α-Dithiosemi- Carbazones. Nature (Lond.) 206, 1340–1341 (1965).
Barry, V. C., Conalty, M. L., McCormick, J. E., McElhenney, K. S., Mcinerney, M. R., O’sullivan, J. F.: Anticancer agents. IV. The antitumor activity of some 1,4- and 1,5- (bisthiosemicarbazones) and of related heterocycles. J. med. Chem. 13, 421–427 (1970).
Booth, B. A., Donnelly, T.E., Jr., Zettner, A., Sartorelli, A.C.: Metabolic effects of zinc in intact cells—comparative studies of zinc chloride and the zinc chelate of kethoxal bis- (thiosemicarbazone). Biochem. Pharmacol. 20, 3109–3118 (1971).
Booth, B. A., Johns, D.G., Bertino,J.R., Sartorelli,A.C.: Sites of inhibition of DNA synthesis by kethoxal bis(thiosemiearbazone). Nature (Lond.) 217, 250–251 (1968).
Booth, B. A., Sartorelli, A. C.: Synergistic interaction of kethoxal bis(thiosemicarbazone) and cupric ions in Sarcoma 180. Nature (Lond.) 210, 104–105 (1966).
Booth, B. A., Sartorelli, A. C.: Metabolic effects of copper in intact cells: comparative activity of cupric chloride and the cupric chelate of kethoxal bis(thiosemicarbazone). Molec. Pharmacol. 3, 290–302 (1967).
Crim, J. A., Petering, H.G.: The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone). Cancer Research 27, 1278–1285
Domagk, G., Behnisch, R., Mietzsch, F., Schmidt, H.: Über eine neue, gegen Tuberkelbazillen in vitro wirksame Verbindungsklasse. Naturwissenschaften 33, 315 (1946).
French, P. A., Freedlander, B. L.: Carcinostatic action of polycarbonyl compounds and their derivatives. IV. Glyoxal bis(thiosemicarbazone) and derivatives. Cancer Res. 18, 1298–1300 (1958).
French, F. A., Freedlander, B. L.: Chemotherapy studies on transplanted tumors. Cancer Res. 21, 505–538 (1960).
Gingras, B. A., Hornal, R.W., Bayley, C.H.: The preparation of some thiosemicarbazones and their copper complexes. I. Canad. J. Chem. 38, 712–719 (1960).
Gingras, B. A., Somarjai, R.L., Bayley, C.H.: The preparation of some thiosemicarbazones and their copper complexes. II. Canad. J. Chem. 39, 973–985 (1961).
Gingras, B. A., Suprunchuk, T., Bayley, C. H: The preparation of some thiosemicarbazones and their copper complexes. III. Canad. J. Chem. 40, 1053–1059 (1962).
Martin, D. S.: Combination adjuvant therapy after surgery for spontaneous breast tumors. Proc. Amer. Ass. Cancer. Res. 4, 42 (1963).
Mcquitty, J. T., Dewys, W. D., Monaco, L., Strain, W. H., Rob, C. G., Apgar, J., Pories, W. J.: Inhibition of tumor growth by dietary zinc deficiency. Cancer Res. 30, 1387–1390 (1970).
Michaels, R. M., Peterson, L. J., Stahl, G.L.: The activity of substituted thiosemicarbazones against T. vaginalis and T. foetus in vitro and in experimental animals. J. Parasitol. 48, 891–897 (1962).
Mihich, E., Mulhern, A. I.: Comparative potency of kethoxal bis(thiosemicarbazone) (KTS) and its copper II chelate (KTS—Cu) in rodents. Fed. Proc. 24, 454 (1965).
Mihich, E., Niöhol, C. A.: Enhanced inhibition of Sarcoma 180 (S180) caused by methyl- glyoxal-bis(N4-methylthiosemicarbazone) (CH3—GMS) and dietary pyridoxine deficiency. Proc. Amer. Ass. Cancer Res. 3, 250 (1961).
Mihich, E., Nichol, C. A.: Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors. Cancer Res. 25, 1410–1416 (1965).
Mihich, E., Simpson, C. L.: Comparative study of α-n-butyryloxyethylglyoxal bis(thiosemi- carbazone) (BGTS) and kethoxal-bis(thiosemicarbazone) (KTS). Pharmacologist 10, 171
Mihich, E., Simpson, C. L., Mulhern, A. I.: Kethoxal bis(thiosemicarbazone). II. Toxic and pathologic effects. Cancer Res. 25, 1417–1431 (1965).
Nettberg, C., Neimann, W.: Eine Methode zur Isolierung von Aldehyden und Ketonen. Ber. 35, 2049–2056 (1902).
Petering, D. H.: CuKTS. I. Physico-chemical properties of the antitumor agent. Bioinorg. Chem. I, 255–271 (1972a).
Petering, D. H.: CuKTS. II. Reactions with thiols. Bioinorg. Chem., I, 273–288 (1972b).
Petering, D. H.: The role of zinc in the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato)zinc (II) and related compounds. Biochem. Pharmacol. 23, 567–576 (1974).
Petering, H. G., Buskirk, H. H.: The antitumor activity of 2-ke to-3-ethoxybutyraldehyde bis(thiosemicarbazone) and related compounds. Fed. Proc. 21, 163 (1962).
Petering, H. G., Buskirk, H. H., Crim, J. A.: Activity of combinations of uracil mustard (NSC-34462) and 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) (KTS, NSC-82116) against murine tumors. Cancer Chemother. Rep. 50, 557–563 (1966 a).
Petering, H. G., Buskirk, H. H., Crim, J. A.: The effect of dietary mineral supplements of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde (thiosemicarbazone). Cancer Res. 27, 1115–1121 (1967).
Petering, H. G., Buskirk, H. H., Crim, J.A., Van Giessen, G. J.: The effect of essential metal ions on the antitumor activity of kethoxal bis(thiosemicarbazone) (KTS). Pharmacologist 5, 271 (1963).
Petering, H. G., Buskirk, H. H., Kupiecki, F.: Chelate formation and antitumor activity of KTS. Fed. Proc. 24, 454 (1965).
Petering, H. G., Buskirk, H. H., Underwood, G. E.: The antitumor activity of 2-keto-3- ethoxybutyraldehyde bis(thiosemicarbazone) and related compounds. Cancer Res. 24, 367–372 (1964).
Petering, H. G., Van Giessen, G. J.: The essential role of cupric ion in the biological activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone), a new antitumor agent. In: Piesach, Aisen, Blumberg (Eds.): The biochemistry of copper, pp. 197–210. New York: Academic Press 1966 b.
Petering, H. G., Van Giessen, G. J., Crim, J. A., Buskirk, H. H.: The synthesis and antitumor activity of several thiosemicarbazones related to kethoxal bis(thiosemicarbazone). J. med. Chem. 9, 420–421 (1966 c).
Regelson, W., Holland, J. F., Talley, R. W.: Clinical pharmacologic study of kethoxal bis- (thiosemicarbazone) (NSC-82116) in advanced cancer. Cancer Chemother. Rep. 51, 171–177 (1967).
Sabtobelli, A. C., Welch, A. D., Booth, B. A.: Biochemical effects of kethoxal bis(thiosemicarbazone) and its cupric chelate. Fed. Proc. 24, 454 (1965).
Van Giessen, G. J., Crim, J. A., Petering, D. H., Petering, H. G.: Effect of heavy metals on the in vitro cytotoxicity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) and related compounds. J. nat. Cancer Inst. 51, 139–146 (1973).
Van Giessen, G. J., Petering, H. G.: Metal complexes of 3-ethoxy-2-oxobutyraldehyde bis-(thiosemicarbazone) and related ligands as antitumor agents. J. med. Chem. 11, 695–699 (1968).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 springer-Verlag Berlin-Heidelberg
About this chapter
Cite this chapter
Petering, D.H., Petering, H.G. (1975). Metal Chelates of 3-Ethoxy-2-Oxobutyraldehyde Bis (Thiosemicarbazone), H2KTS. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65806-8_48
Download citation
DOI: https://doi.org/10.1007/978-3-642-65806-8_48
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65808-2
Online ISBN: 978-3-642-65806-8
eBook Packages: Springer Book Archive